Alexion Pharmaceuticals, Inc. (ALXN)

182.50
Prev Close 182.50
Day Low/High 0.00 / 0.00
52 Wk Low/High 99.91 / 187.45
Exchange
Div & Yield N.A. (N.A)
Cramer: Reviewing S&P's Hit-and-Miss Parade

Cramer: Reviewing S&P's Hit-and-Miss Parade

Even among the losers, buys are scarce.

Dump These 5 'Toxic Stocks' Before the New Year

Dump These 5 'Toxic Stocks' Before the New Year

Start 2017 on the right foot by selling your holdings in these five stocks.

Alexion Fires CEO, CFO in the Midst of Investigation on Improper Sales Practices

Alexion Fires CEO, CFO in the Midst of Investigation on Improper Sales Practices

Alexion Pharmaceuticals has fired its CEO and CFO as an ongoing investigation into sales practices continues.

Alexion upgraded at Barclays

Takeover Talk Surrounds Biotech Firm Alexion, Says Jim Cramer

Takeover Talk Surrounds Biotech Firm Alexion, Says Jim Cramer

Jim Cramer explains the recent moves in biotechs and comments on reports regarding a Justice Department investigation into generic drug makers.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Here's a window into what institutional investors may be doing and how to profit from that.

Alexion upgraded at Goldman

Alexion upgraded at Credit Suisse

Rev's Forum: Don't Be Seduced by the Market's Dark Side

Too many turn bearish too quickly just because they can't find any entry points.

Trader's Daily Notebook: Gusher for Oil Stocks

Trader's Daily Notebook: Gusher for Oil Stocks

Big move for biotechs isn't pleasant.

Here’s Why Shares of Biogen and Alexion Tanked On Tuesday

Here’s Why Shares of Biogen and Alexion Tanked On Tuesday

Shares of Biogen and Alexion Pharmaceuticals took a hit Tuesday after their promising new products failed clinical trials.

Trending Tickers: Z, VRX, BIIB, ALXN

U.S. indices are up as oil continues its climb past $50 a barrel.

Alexion upgraded at BMO

U.S. Futures and World Markets Blindsided by Bank of Japan Decision

U.S. Futures and World Markets Blindsided by Bank of Japan Decision

Crude prices were also falling following the BOJ's decision to keep its monetary policy unchanged. 

Alexion Pharmaceuticals' Big Top Foreshadows Big Drop

Alexion Pharmaceuticals' Big Top Foreshadows Big Drop

The next potential support levels are the $120 and $100 areas from 2013.

Novice Trade: Illumina

Novice Trade: Illumina

ILMN's three-month at-the-money implied volatility is at about the median level.

Alexion upgraded at Morgan Stanley

Alexion downgraded at Barclays

Deluge of Deals Isn't About to Dry Up

Acquisitions cut into overabundance of companies.

3 Fantastic Pharmaceutical Stocks: Abbvie, Vertex and Biogen

3 Fantastic Pharmaceutical Stocks: Abbvie, Vertex and Biogen

AbbVie is a cheap stock and worries about competition immediately hurting its rheumatoid arthritis drug Humira are overblown, said John Schroer, Portfolio Manager for the AllianzGI Health Sciences Fund.

Market Wrap: Yellen Delivers a Jolt

Market Wrap: Yellen Delivers a Jolt

U.S. stocks fell for a second straight session.

Microsoft Lags Dow in Tech Selloff; Yellen Spooks Wall Street

Microsoft Lags Dow in Tech Selloff; Yellen Spooks Wall Street

Stocks pared losses, though remained in the red by close as markets weighed comments from Federal Reserve Chair Janet Yellen that equity valuations were possibly stretched.

Herbalife Beats Estimates; Stocks Open Slightly Higher as Crude Rallies

Herbalife Beats Estimates; Stocks Open Slightly Higher as Crude Rallies

Herbalife (HLF) rallied after boosting full-year earnings forecasts as sales in China showed strength.

The 7 Pillars of Healthcare Strength

The 7 Pillars of Healthcare Strength

Here are healthcare stocks of all shares and sizes with strong charts.

Braving Biotech

Do you need to pick one name? Biotech has carried with it a lasting resiliency like few other sectors. Perhaps it is driven by optimism and hope. Perhaps it is driven by the fear of suffering or watching someone suffer from the very illnesses these ...

Those Sensitive Biotechs

They are prone to being whipsawed by news.

Alexion downgraded at Morgan Stanley

The Trader Daily

The Trader Daily

A few stocks that could break higher.

Why You Should Watch Fibonacci Extensions

Why You Should Watch Fibonacci Extensions

As these examples illustrate, it's just good risk management.